Dellamonica P
Maladies Infectieuses et Tropicales, Hôpital de l'Archet, BP 689, F-06012 Nice, France.
Med Mal Infect. 1992 Feb;22:149-152. doi: 10.1016/S0399-077X(05)81464-7. Epub 2005 Jun 20.
Acute bronchitis in healthy patient in mainly related to virus. Intra-cellular bacteria, are rarely involved. For these reasons, macrolides or cyclines (except for children) are justified in first line treatment. For patients with acute exacerbation of chronic bronchitis, the choice of the treatment needs to be discuss. At the initial stage, most of the pathogens involved are those of acute bronchitis. Antibiotic is only prescribes for the prevention of a superinfection; this kind of prophylaxis has to be evaluated. Few days after, histological due to modifications of bronchi, a superinfection can occur which needs a curative treatment. In most of the data reported the literature, there is no distinction between the two periods of the disease. It is interesting to point out that associated treatments such as kinesitherapy, corticosteroids can modify the natural course of bronchitis. There are not evaluated as associated treatment in the different clinical trials.
健康患者的急性支气管炎主要与病毒有关。细胞内细菌很少涉及。出于这些原因,大环内酯类或四环素类(儿童除外)作为一线治疗是合理的。对于慢性支气管炎急性加重的患者,治疗方案的选择需要讨论。在初始阶段,涉及的大多数病原体与急性支气管炎相同。抗生素仅用于预防二重感染;这种预防措施必须进行评估。几天后,由于支气管的组织学改变,可能会发生二重感染,这需要进行根治性治疗。在文献报道的大多数数据中,并未区分疾病的这两个阶段。值得指出的是,诸如运动疗法、皮质类固醇等辅助治疗可以改变支气管炎的自然病程。在不同的临床试验中,它们并未作为辅助治疗进行评估。